{
    "2020-12-07": [
        [
            {
                "time": "",
                "original_text": "医药生物行业跨市场周报：政策压制效应渐弱 重点把握核心资产价值",
                "features": {
                    "keywords": [
                        "医药生物",
                        "政策压制",
                        "核心资产"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "大参林(603233.SH)：2020年员工持股计划累计买入547.7万股",
                "features": {
                    "keywords": [
                        "大参林",
                        "员工持股计划",
                        "买入"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "接续减持股份、可转债 大参林股东纷纷“出手”背后谁来接盘？ 可转债减持",
                "features": {
                    "keywords": [
                        "大参林",
                        "减持",
                        "可转债"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：狂犬单抗未来会是大品种吗？再次强调12月是医药底部布局期",
                "features": {
                    "keywords": [
                        "医药生物",
                        "狂犬单抗",
                        "底部布局"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：医药反弹OR反抽？",
                "features": {
                    "keywords": [
                        "医药",
                        "反弹",
                        "反抽"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}